​
​

Acasti Pharma Stock (NASDAQ:ACST)

OwnershipFinancialsChart
Acasti Pharma by TradingView

Previous Close

$3.24

52W Range

$1.98 - $3.60

50D Avg

$3.05

200D Avg

$2.99

Market Cap

$34.17M

Avg Vol (3M)

$33.25K

Beta

1.52

Div Yield

-

ACST Company Profile

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

32

IPO Date

Feb 07, 2012

Website

ACST Performance

ACST Financial Summary

Mar 24Mar 23Mar 22
Revenue---
Operating Income$-23.71M$15.72M$-15.59M
Net Income$-14.69M$-42.43M$-9.82M
EBITDA$-23.71M$15.85M$-19.99M
Basic EPS$-1.54$-5.71$-1.60
Diluted EPS$-1.54$-5.71$-1.60

Fiscal year ends in Mar 24 | Currency in USD

Latest Earnings Call Transcripts

Q3 23Feb 14, 23 | 3:53 PM
Q2 23Nov 14, 22 | 11:23 PM
Q1 23Aug 11, 22 | 3:55 PM

Peer Comparison

TickerCompany
GOVXGeoVax Labs, Inc.
ARDSAridis Pharmaceuticals, Inc.
PULMPulmatrix, Inc.
ABVCABVC BioPharma, Inc.
BPTHBio-Path Holdings, Inc.
ADTXAditxt, Inc.
TNXPTonix Pharmaceuticals Holding Corp.
DFFNCervoMed Inc.
AKTXAkari Therapeutics, Plc
JAGXJaguar Health, Inc.
MBRXMoleculin Biotech, Inc.
ONTXTraws Pharma, Inc.
CBIOGyre Therapeutics, Inc.
OCGNOcugen, Inc.